SHENZHEN, China--(BUSINESS WIRE)--Fibocom (Stock Code: 300638), a leading global provider of IoT (Internet of Things) wireless solution and wireless communication modules, releases its latest 5G LGA ...

Something to look forward to: With the reveal and launch of AMD's new Ryzen 7000 series of processors drawing closer, engineering samples of the processors have begun to reach partners and ...

StoreDot first promised to release a fast-charging cell in 2015. In 2017, it made a demonstration that these batteries did what it said they would. In 2019, when they could be already for sale, ...

Microchip Technology has announced significant advancements in its Radiation-Tolerant (RT) PolarFire® technology, achieving MIL-STD-883 Class B and QML Class Q qualifications for the RT PolarFire ...

Something to look forward to: The 11700K could perform similarly to current flagships, or it could perform better if Intel refines it ahead of release. We don't generally condone reviewing processors ...

The first key information that can be gleaned from the data provided is that of the two engineering samples listed, one is an 8-core/16-thread design whereas the other is a 16-core/32-thread model.

SHANGHAI--(BUSINESS WIRE)--Montage Technology, a leading data processing and interconnect IC design company, today announced that it has shipped the world’s first Gen3 registering clock driver (RCD or ...

Engineering samples of xMEMS’ Sycamore and Cypress MEMS (micro-electromechanical systems) nearfield full bandwidth speaker chips, along with the company’s µCooling thermal management “air pump on a ...

Toshiba’s new IC comes in a compact 6mm×6mm P-VQFN36-0606-0.50 package. Credit: Alexander Tolstykh/Shutterstock. Toshiba Electronics Europe has started offering engineering samples of its TB9084FTG, a ...

Less than a month from Intel Innovation, the rumoured official reveal event for Intel's Alder Lake processors, black market vendors in China are reportedly selling numerous Intel Core i9-12900K ...

NESS ZIONA, Israel--(BUSINESS WIRE)-- BiomX Inc. (NYSE American: PHGE), a clinical stage company developing natural and engineered phage therapies targeting specific pathogenic bacteria, today ...